Schedule of test monitoring costs and royalty fees |
|
|
Twelve months ended March 31,
|
|
Nine months ended December 31,
|
|
|
|
2016
|
|
2017
|
|
2017
|
|
|
|
RMB
|
|
RMB
|
|
RMB
|
|
|
|
|
|
|
|
|
|
Test monitoring costs
|
|
142,116,286
|
|
163,061,810
|
|
191,809,319
|
|
Royalty fees
|
|
4,823,101
|
|
7,423,118
|
|
7,406,065
|
|
|
Schedule of allocation of recognized employee benefit expenses |
|
|
Twelve months ended March 31,
|
|
Nine months ended December 31,
|
|
|
|
2016
|
|
2017
|
|
2017
|
|
|
|
RMB
|
|
RMB
|
|
RMB
|
|
Cost of revenues
|
|
6,334,414
|
|
6,841,587
|
|
5,312,695
|
|
Research and development
|
|
5,810,237
|
|
6,435,010
|
|
5,952,564
|
|
Sales and marketing
|
|
4,169,401
|
|
4,463,283
|
|
4,228,981
|
|
General and administrative
|
|
2,583,837
|
|
3,110,561
|
|
2,709,508
|
|
|
|
|
|
|
|
|
|
Total expense due to employee benefit plans
|
|
18,897,889
|
|
20,850,441
|
|
18,203,748
|
|
|
|
|
|
|
|
|
|
|